Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes
Open accessThe DOI matches its Crossref record; 110 of the 115 references it cites were found in a registry or an index; 22 of the 65 sources its claims cite were checked for support.
Abstract
Insulin resistance is a characteristic feature of type 2 diabetes and plays a major role in the pathogenesis of the disease (1,2). Although �-cell failure is the sine qua non for development of type 2 diabetes, skeletal muscle insulin resistance is considered to be the initiating or primary defect that is evident decades before �-cell failure and overt hyperglycemia develops (3,4). Insulin resistance is defined as a reduced response of target tissues (compared with subjects with normal glucose tolerance [NGT] without a family history of diabetes), such as the skeletal muscle, liver, and adipocytes, to
Overview
CoChat Summary
TL;DR
This review argues that skeletal muscle insulin resistance—especially impaired glycogen synthesis—is the initiating/primary defect in most type 2 diabetes, preceding β-cell failure and overt hyperglycemia. It concludes that overt diabetes requires β-cell failure to supervene, while muscle insulin resistance is already evident in normal glucose-tolerant high-risk relatives and prospective populations.
Key findings
- Skeletal muscle is the predominant site of insulin-mediated postprandial glucose uptake: under euglycemic hyperinsulinemia, ∼80% of glucose uptake occurs in skeletal muscle; leg muscle glucose uptake plateaus at ∼10 mg/kg leg weight per minute after 60 min, and in lean type 2 diabetic subjects it is reduced by ∼50% during the last hour of the insulin clamp.
- In lean NGT offspring of two type 2 diabetic parents, a two-step euglycemic clamp (20 and 40 mU/m² per min; plasma insulin ∼40 and ∼80 μU/ml) showed glucose uptake decreased by 33% and 43%, respectively; the impairment was accounted for entirely by reduced nonoxidative glucose metabolism/glycogen synthesis, with no defect in insulin suppression of hepatic glucose production.
- Prospective Pima Indian data showed both progressors and nonprogressors had a further 11–14% reduction in insulin sensitivity; nonprogressors increased insulin secretion by 30%, whereas progression to type 2 diabetes was associated with a 78% decline in the acute insulin response to intravenous glucose.
- Hyperinsulinemia itself worsens muscle insulin resistance: a 72 pmol/l (11 μU/ml) increase in plasma insulin for 72–96 h reduced insulin-stimulated glucose disposal by 30–40%, entirely via impaired nonoxidative glucose disposal; in rats, 7-day hyperinsulinemia reduced total-body glucose uptake, storage, and glycolysis by 39%, 62%, and 26%. Mitochondrial ATP production increased by 90% in NGT subjects without family history but only 5% in insulin-resistant offspring.
Methods
- Narrative review/symposium article; no primary study design or new sample. It synthesizes human studies using the euglycemic insulin clamp (described as the gold standard), indirect calorimetry, muscle biopsy, femoral/forearm catheterization, PET, NMR spectroscopy, OGTT, and prospective follow-up.
- Populations discussed include lean NGT first-degree relatives/offspring of two type 2 diabetic parents, Mexican Americans, Pima Indians, Caucasians in San Antonio, and type 2 diabetic subjects. Main analysis is qualitative synthesis of cited evidence.
Limitations
- Stated: by the time hyperglycemia is manifest, multiple abnormalities (elevated glucose, FFA, and cytokines) coexist, making it extremely difficult to separate each defect’s contribution; at initial presentation it is not possible to define which defect came first.
- Stated: it is unclear whether mitochondrial dysfunction leads to increased intramyocellular lipid and insulin resistance or increased muscle lipid leads to mitochondrial dysfunction and insulin resistance (“which is the cart and which is the horse”).
- Evident: as a narrative review, it lacks systematic search, formal quality assessment, or meta-analysis; conclusions depend on selected cited studies, and several figures are in an online appendix rather than the text.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
14 Valid · 1 Not valid · 22 Not checked · 11 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“In type 2 diabetes, impaired glycogen synthesis secondary to reduced glycogen synthase activity is the earliest detectable metabolic defect ( 39 – 41 ).”
What the sources say
- Not matchedcites [39] DeFronzo, 1997, Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying genes, Diabetes Rev
We searched by its title and found no matching paper.
- Partly supportedcites [40] Bogardus, 1984, Correlation between muscle glycogen synthase activity and in vivo insulin action in man, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion (page unavailable) reports a correlation between muscle glycogen synthase activity and insulin-mediated glucose storage in glucose-tolerant and diabetic subjects. It hypothesizes a link between reduced enzyme activity and impaired glucose handling, but does not establish that one causes the other or that impaired glycogen synthesis is the earliest detectable metabolic defect in type 2 diabetes. (LLM, conf=0.86)
- Not checked — no full text of the sourcecites [41] Shulman, 1990, Quantitation of muscle glycogen synthesis in normal subjects and subjects with non-insulin-dependent diabetes by 13C nuclear magnetic resonance spectroscopy, N Engl J Med source
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Not matched
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Maintaining the integrity of the IRS-1/PI-3 kinase/Akt pathway is essential for normal insulin-mediated glucose uptake in skeletal muscle ( 26 ).”
What the sources say
- Partly supportedcites [26] Krook, 2000, Characterization of signal transduction and glucose transport in skeletal muscle from type 2 diabetic patients, Diabetes sourceExperimental — accuracy not yet measured
The paper’s introduction identifies IRS-1 and PI 3-kinase as components of insulin signaling involved in skeletal-muscle glucose transport. Its study summary says reduced PI 3-kinase activity may partly account for reduced insulin-stimulated glucose transport, while additional defects contribute. The cited passages do not establish a role for Akt or show that integrity of the entire pathway is essential for normal uptake. (LLM, conf=0.88)
states a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on an assumption not shown here.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Multiple investigators unequivocally have demonstrated that lean NGT offspring of two parents with type 2 diabetes exhibit moderate to severe skeletal muscle insulin resistance ( 28 – 33 ).”
What the sources say
- Not checked — no full text of the sourcecites [28] Perseghin, 1997, Metabolic defects in lean nondiabetic offspring of NIDDM parents: a cross-sectional study, Diabetes source
- Not checked — no full text of the sourcecites [29] Ferrannini, 2003, Influence of ethnicity and familial diabetes on glucose tolerance and insulin action: a physiological analysis, J Clin Endocrinol Metab source
- Not checked — no full text of the sourcecites [30] Kashyap, 2004, Discordant effects of a chronic physiological increase in plasma FFA on insulin signaling in healthy subjects with or without a family history of type 2 diabetes, Am J Physiol Endocrinol Metab source
- Partly supportedcites [31] Vaag, 1992, Decreased insulin activation of glycogen synthase in skeletal muscles in young nonobese Caucasian first-degree relatives of patients with non-insulin-dependent diabetes mellitus, J Clin Invest sourceExperimental — accuracy not yet measured
The Subjects section says the participants were nonobese, had normal oral glucose tolerance, and had at least one parent with NIDDM—not necessarily two. The Discussion reports skeletal-muscle insulin resistance but also considerable overlap with controls; it does not establish moderate-to-severe resistance in offspring of two affected parents. Page numbers are unavailable in our copy. (LLM, conf=0.88)
- Not checked — no full text of the sourcecites [32] Gulli, 1992, The metabolic profile of NIDDM is fully established in glucose-tolerant offspring of two Mexican-American NIDDM parents, Diabetes source
- Not checked — no full text of the sourcecites [33] Tripathy, 2003, Familiality of metabolic abnormalities is dependent on age at onset and phenotype of the type 2 diabetic proband, Am J Physiol source
boostedstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“In lean insulin-resistant NGT offspring of type 2 diabetic parents, increased serine phosphorylation of IRS-1 in skeletal muscle has been documented in association with impaired activation of Akt ( 57 ) (Fig. A11).”
What the sources say
- Supportedcites [57] Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest source
The Introduction describes the offspring as young, lean, normoglycemic, and insulin-resistant. The Results report increased IRS-1 serine phosphorylation and reduced insulin-stimulated Akt phosphorylation in the offspring, and the Discussion explicitly describes these findings as associated. Page numbers are not provided in our copy. (LLM, conf=0.94)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“This observation is of important clinical significance, since diacylglycerol, long-chain fatty acyl CoAs, and ceramides all have been shown to cause serine phosphorylation of insulin resistance and IRS-1 and lead to the development of insulin resistance in skeletal muscle ( 59 , 60 ).”
What the sources say
- Not checked — no full text of the sourcecites [59] Hotamisligil, 1996, IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance, Science source
- Partly supportedcites [60] Jiang, 1999, Characterization of selective resistance to insulin signaling in the vasculature of obese Zucker (fa/fa) rats, J Clin Invest sourceExperimental — accuracy not yet measured
The Discussion says elevated free fatty acids may impair insulin’s metabolic action and notes protein kinase C activation in skeletal muscle. It does not say that diacylglycerol, long-chain fatty acyl CoAs, or ceramides cause IRS-1 serine phosphorylation and thereby produce skeletal-muscle insulin resistance; its serine-phosphorylation discussion concerns the insulin receptor instead. Page numbers are unavailable in our copy. (LLM, conf=0.83)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
21 more claims · 6 with their cited sources checked
Create a free account to see all 48 claims and to verify the 1 reference still open.
- Probably not a substantial claim. 4
- It may state two separate claims as one. 20
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Various epidemiological and experimental studies have shown that muscle weakness, decreased muscle mass, reduced activation of glycogen synthase, and alterations in the numbers of glycolytic skeletal muscle fibers are related to, and may precede, insulin resistance, glucose intolerance, and T2D [332,333].”
From Global consensus on optimal exercise recommendations for enhancing healthy longevity in older adults (ICFSR) (2025) · cites this paper as [333]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Even though pancreatic beta cell dysfunction is the main pathogenesis of type 2 diabetes mellitus, given that the uptake of postprandial glucose by skeletal muscles is approximately 80–90%, skeletal muscle IR plays a crucial role in the development and progression of diabetes mellitus [129,130].”
From Sarcopenic obesity, insulin resistance, and their implications in cardiovascular and metabolic consequences (2020) · cites this paper as [130]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Dysregulation of these processes contributes to the pathogenesis of numerous diseases, including diabetes and obesity (DeFronzo and Tripathy, 2009; Sugden et al., 2009), mitochondrial disorders (Kerr, 2013), cardiac failure (Fillmore and Lopaschuk, 2013), neurodegenerative disorders (Cunnane et al., 2011; Yao et al., 2011), and cancer (Currie et al., 2013; Tennant et al., 2010).”
From Regulation of Substrate Utilization by the Mitochondrial Pyruvate Carrier (2014) · cites this paper as DeFronzo and Tripathy, 2009
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Furthermore, the SM accounts for >80% of glucose uptake in the post-prandial period following an oral glucose load, with linear increases in uptake over time [17,20].”
From Optimised Skeletal Muscle Mass as a Key Strategy for Obesity Management (2025) · cites this paper as [20]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Skeletal muscle is the main tissue responsible for insulin-stimulated glucose disposal and an impaired uptake is common in obesity and has substantial impact on whole-body glucose turnover.8,9”
From Changes in lean body mass with glucagon‐like peptide ‐1‐based therapies and mitigation strategies (2024) · cites this paper as [8]
Experimental — accuracy not yet measured
7 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Role of Insulin Resistance in Human Disease
Reaven, G. M. (1988) · Diabetes · doi:10.2337/diab.37.12.1595 · Cited by 12,154
Mootha, V. K., Lindgren, C. M., Eriksson, K.-F., Subramanian, A., Sihag, S., Lehar, J., Puigserver, P., Carlsson, E., Ridderstråle, M., Laurila, E., et al. (2003) · Nature Genetics · doi:10.1038/ng1180 · Cited by 10,197
Glucose clamp technique: a method for quantifying insulin secretion and resistance.
DeFronzo, R. A., Tobin, J. D., & Andres, R. (1979) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1979.237.3.e214 · Cited by 7,425 · cited 1×
“RESEARCH DESIGN AND METHODS — The euglycemic insulin clamp technique (5) is considered to be the gold standard for measuring insulin action in vivo.”
BackgroundSelf-citationMatsuda, M., & DeFronzo, R. A. (1999) · Diabetes Care · doi:10.2337/diacare.22.9.1462 · Cited by 5,621 · cited 1×
“70) with insulin sensitivity measured with the euglycemic insulin clamp (9).”
MethodSelf-citationKatz, A., Nambi, S. S., Mather, K., Baron, A. D., Follmann, D. A., Sullivan, G., & Quon, M. J. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6661 · Cited by 3,931
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,225
Critical nodes in signalling pathways: insights into insulin action
Taniguchi, C. M., Emanuelli, B., & Kahn, C. R. (2006) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1837 · Cited by 2,760 · cited 1×
“This results in activation of downstream protein kinase B (also called Akt) and phosphorylation of Akt substrate 160 (AS160), which facilitates the translocation of GLUT4 to the sarcolemma and subsequent entry of glucose into the cell (25).”
BackgroundHotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
The Triumvirate: β-Cell, Muscle, Liver: A Collusion Responsible for NIDDM
DeFronzo, R. A. (1988) · Diabetes · doi:10.2337/diab.37.6.667 · Cited by 2,456 · cited 7×
“Because the majority of type 2 diabetic subjects are obese, they also have daylong elevation of the plasma free fatty acid (FFA) concentration and increased circulating levels of inflammatory cytokines (1,2).”
BackgroundInfluentialSelf-citation
Research works printed but not linked: 2
- Pendergrass, 2007, Muscle glucose transport and phosphorylation in type 2 diabetic, obese nondiabetic, and genetically predisposed individuals, Am J Physiol Endocrinol Metab, 292, E92, 10.1152/ajpendo.00617.2005 · DOI · Paper page
- Morino, 2005, Reduced mitochondrial density and increased IRS-1 serine phosphorylation in muscle of insulin-resistant offspring of type 2 diabetic parents, J Clin Invest, 115, 3587, 10.1172/jci25151 · DOI · Paper page
Cited by
Items 1,501–1,600 of 2,099
Brugnara, L., García-Díez, A. I., Murillo, S., Ribalta, J., Fernández, G., Marquez, S., Rodriguez, M. A., Vinaixa, M., Amigó, N., Correig, X., et al. (2022) · European Journal of Applied Physiology · doi:10.1007/s00421-022-04929-z · Cited by 3
“2007; DeFronzo and Tripathy 2009; Zierath et al.”
Rydosz, A. M. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99887-1.00001-7 · Cited by 4
Prodanović, R., Kirovski, D., Vujanac, I., Djordjevic, A. D., Romić, S., Pantelić, M., & Korićanac, G. (2022) · Research in Veterinary Science · doi:10.1016/j.rvsc.2022.04.012 · Cited by 4
Archer, E., & Hill, J. O. (2022) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2022.10.003 · Cited by 6
Association between Lower-to-Upper Ratio of Appendicular Skeletal Muscle and Metabolic Syndrome
Moon, H. E., Lee, T., & Chung, T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11216309 · Cited by 4
“Therefore, loss of ASM could drive metabolic impairments [5].”
BackgroundFarrokhnia, M., Amoabediny, G., Ebrahimi, M., et al. (2022) · Microchimica Acta · doi:10.1007/s00604-022-05503-2 · Cited by 3
“Insulin resistance, defined as the inability of insulin targets to respond properly to insulin, is one of the key contributors to type 2 diabetes [48].”
BackgroundChronic Alcohol and Skeletal Muscle
Bourgeois, B. L., Levitt, D. E., Molina, P. E., & Simon, L. (2022) · Springer eBooks · doi:10.1007/978-3-030-92392-1_49 · Cited by 6
Age-Dependent Skeletal Muscle Mitochondrial Response to Short-Term Increased Dietary Fructose
Gatto, C., Porzio, A. D., Crescenzo, R., Barrella, V., Iossa, S., & Mazzoli, A. (2023) · Antioxidants · doi:10.3390/antiox12020299 · Cited by 5
“Since the glucose buffering capacity after glucose loading is primarily determined by the skeletal muscle metabolic response to insulin [29], downstream targets of the insulin signaling pathway, named p-Akt, p-GSK and GLUT-4, were evaluated in the skeletal muscle of fructose-fed rats, and significantly lower values we…”
ResultAhmad, A. H. M., Kamal, M., & Rashed, M. M. (2023) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2023.07.004 · Cited by 3
Callegari, S., Fehér, A., Smolderen, K. G. E., Mena‐Hurtado, C., & Sinusas, A. J. (2024) · American Heart Journal Plus Cardiology Research and Practice · doi:10.1016/j.ahjo.2024.100400 · Cited by 6
Szalanczy, A., Sherrill, C., Fanning, K. M., Hart, B. P., Caudell, D. L., Davis, A. W., Whitfield, J. M., & Kavanagh, K. (2024) · Radiation Research · doi:10.1667/rade-23-00202.1 · Cited by 3
“Improved insulin responsiveness will support normal tissue perfusion and nutrient uptake, both key for the protective effects on peripheral tissues such as adipose and skeletal muscle ( 46 – 48 ).”
BackgroundNitric oxide in modulating oxidative stress mediated skeletal muscle insulin resistance
Anwar, A., Shukla, S., & Pathak, P. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09874-y · Cited by 6
“Insulin stimulated glucose uptake in skeletal muscle is crucial for maintaining whole-body glucose homeostasis thus muscular IR could affect whole body metabolism [35, 36].”
Protein Extraction Methods Suitable for Muscle Tissue Proteomic Analysis
Vantaggiato, L., Landi, C., Shaba, E., Rossi, D., Sorrentino, V., & Bini, L. (2024) · Proteomes · doi:10.3390/proteomes12040027 · Cited by 4
Westcott, F., Nagarajan, S. R., Parry, S. A., Savic, D., Green, C., Marjot, T., Johnson, E. M., Cornfield, T., Mózes, F. E., O’Rourke, P., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae123 · Cited by 6
“35,36 The HI and HF groups in the current study had moderately raised plasma glucose concentrations, and it is likely that increased fasting frGNG may only be observed in those with severe hyperglycemia, 37,38 suggesting GNG may have a larger contribution to fasting hyperglycemia in those with more…”
Ryu, H. E., Heo, S., Lee, J. H., Park, B., Han, T., & Kwon, Y. (2025) · Endocrine · doi:10.1007/s12020-024-04154-y · Cited by 3
“IR is characterized by a diminished reaction to insulin in speci fi c tissues like skeletal muscle, liver, and adipose tissue [26].”
Iniguez, A. B., Du, ., & Zhu, M. J. (2025) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2025.105106 · Cited by 3
Impact of Type 2 Diabetes on Skeletal Muscle Mass and Quality
Sala, D., & Zorzano, A. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-801585-8.00007-5 · Cited by 3
Mohammadi, A., Danesh, B., Fallah, H., et al. (2017) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 3
Preventive and Therapeutic Effects of Dietary Fibers Against Cardiovascular Diseases
Raman, M., Ambalam, P. S., & Doble, M. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811442-1.00012-2 · Cited by 3
khavidaki, M. H. D., Faramarzi, M., Jazi, A. A., & Banitalebi, E. (2018) · Scientific Journal of Kurdistan University of Medical Sciences · doi:10.29252/sjku.23.2.92 · Cited by 3
Oliveira, V. P., Carvalho, L. D. S., da Paz, S. M. R. S., & dos Santos, M. M. (2020) · Revista Eletrônica Acervo Saúde · doi:10.25248/reas.e2105.2020 · Cited by 13
Skeletal muscle clock and metabolism
Li, Y., & Chen, W. (2020) · Biological Rhythm Research · doi:10.1080/09291016.2020.1816037 · Cited by 3
“Insulin resistance in muscle tissue is one of the earliest factors in the pathogenesis of metabolic syndrome (Rabol et al. 2011), an early hallmark of obesity-related metabolic disorders (Meng et al. 2017), and a major pathological characteristic of type 2 diabetes (DeFronzo and Tripathy 2009).”
BackgroundTakao, N., Iwasaka, J., Kurose, S., Miyauchi, T., Tamanoi, A., Tsuyuguchi, R., Fujii, A., Tsutsumi, H., & Kimura, Y. (2021) · Journal of Physical Therapy Science · doi:10.1589/jpts.33.94 · Cited by 2
Cheimonidi, C., Grivas, I. N., Sesti, F., Kavrochorianou, N., Gianniou, D. D., Taoufik, E., Badounas, F., Papassideri, I. S., Rizzi, F., Tsitsilonis, O., et al. (2021) · Aging · doi:10.18632/aging.202788 · Cited by 4
“, skeletal muscle, liver, and adipose tissue) and are signs of metabolic syndrome/INS resistance that can lead to diabetes and atherosclerosis [15].”
BackgroundRegenerative Rehabilitation in Sarcopenia, Dynapenia, and Frailty
Baumann, C. W., Clark, B. C., Phillips, B. E., Szewczyk, N. J., & Consitt, L. A. (2022) · Physiology in health and disease · doi:10.1007/978-3-030-95884-8_5 · Cited by 4
Ghosh, S., Khatoon, R., Sarkar, S., & Bandyopadhyay, D. (2023) · Melatonin Research · doi:10.32794/mr112500138 · Cited by 3
Aizawa, Y., Shirai, T., Kobayashi, T., Hino, O., Tsujii, Y., Inoue, H., Kazami, M., Tadokoro, T., Suzuki, T., Kobayashi, K., et al. (2016) · Bioscience Biotechnology and Biochemistry · doi:10.1080/09168451.2016.1165603 · Cited by 3
Tueller, D. J., Harley, J. S., & Hancock, C. R. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.08.101 · Cited by 5
Schmiedt, R. A., Tiucă, R. A., Tilinca, R. M., Custură, L. M., Deteșan, O., Bacso, B. I., Abalasei, B. L., Bell, A. C., Streza, M. A., & Tilinca, M. C. (2021) · Acta Marisiensis. Seria Medica · doi:10.2478/amma-2021-0033 · Cited by 5
“Skeletal muscle IR can occur more than a decade before the onset of symptomatic T2DM [18].”
BackgroundMetabolic Inheritance and the Competition for Calories between Mother and Fetus
Archer, E., Lavie, C. J., Dobersek, U., & Hill, J. O. (2023) · Metabolites · doi:10.3390/metabo13040545 · Cited by 3
Kwon, Y., Kwon, J., Kim, J., Kim, D., Hwang, J., Ha, J., Park, S., & Park, S. S. (2023) · Journal of the American College of Surgeons · doi:10.1097/xcs.0000000000000868 · Cited by 3
Developmental Origins of Insulin Resistance and Type 2 Diabetes
Ozanne, S. E., & Siddle, K. (2011) · Wiley eBooks · doi:10.1002/9781444347319.ch4 · Cited by 4
Gopal, K., Abdualkader, A. M., Li, X., Greenwell, A. A., Karwi, Q. G., Saed, C. T., Uddin, G. M., Darwesh, A. M., Jamieson, K. L., Altamimi, T., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.05.10.540277 · Cited by 3
San-Millán, I., Martinez, J. L., Sparagna, G. C., D’Alessandro, A., Stefanoni, D., Nemkov, T. G., & Hill, J. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.08.19.608601 · Cited by 4
“Skeletal muscle is responsible for ~80-85% of glucose disposal under resting and hyperinsulinemic-euglycemic postprandial conditions (DeFronzo & Tripathy, 2009) and therefore a critical site for studying cellular metabolism, mitochondrial function and bioenergetics.”
Nishino, K., Bloss, G., Kitzman, J. O., Parker, S. C. J., & Tovar, A. (2024) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2024.11.28.625886 · Cited by 4
Wlazlo, N. (2014) · Research Publications (Maastricht University) · doi:10.26481/dis.20140514nw · Cited by 3
Istikharah, R., Nugrahaningsih, D. A. A., Sadewa, A. H., & Wahyuningsih, M. S. H. (2022) · Malaysian Journal of Medical Sciences · doi:10.21315/mjms2022.29.3.5 · Cited by 8
“This occurs because skeletal muscle is a predominant target for glucose uptake mediated by insulin, especially during postprandial conditions (2).”
BackgroundJayathilake, W. M. N. K., de Laat, M. A., Furr, M., Risco, C. A., & Lacombe, V. A. (2023) · The Veterinary Journal · doi:10.1016/j.tvjl.2023.106053 · Cited by 2
Liu, Y., Hao, L., Yin, C., Li, M., & Xiao, Y. (2024) · Annals of Nutrition and Metabolism · doi:10.1159/000536433 · Cited by 2
“Insulin resistance is a key feature of metabolic syndrome and a major risk factor for type 2 diabetes and cardiovascular diseases [4].”
Yoshizaki, H., Kawaharada, R., Tsutsumi, S., Okami, H., Toriumi, A., Miyata, E., & Nakamura, A. (2024) · Nutrients · doi:10.3390/nu16121898 · Cited by 3
“The skeletal muscle is responsible for approximately 80% of blood glucose uptake and plays a crucial role in maintaining normal blood glucose levels [19].”
BackgroundCarnosinase inhibition enhances reactive species scavenging in high fat diet
Lavilla, C. A., Billacura, M. P., Khatun, S., Cotton, D. P., Lee, V. K., Bhattacharya, S., Caton, P., Sale, C., Wallis, J. D., Garner, A. C., et al. (2025) · Life Sciences · doi:10.1016/j.lfs.2025.123448 · Cited by 3
“Given that impaired insulin-stimulated muscle glucose uptake is common in people with obesity and is a major risk factor for type 2 diabetes [26,27], potential drug candidates were next investigated for biological action on skeletal muscle cell myotubes using glucose-uptake assays (Fig.”
Enhanced glucose regulation potential of C-peptide mimics
Boruah, A., Afzal, N. U., Saha, S., Mazumdar, A., Ozah, D., Bora, T., Prabhakaran, P., Manna, P., & Roy, A. (2025) · Organic & Biomolecular Chemistry · doi:10.1039/d5ob00318k · Cited by 4
Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice
Turner, K., Qian, Y., Claflin, D. R., Newell‐Stamper, B. L., Peter, A. K., Michele, D. E., Russell, A. J., & Brooks, S. V. (2025) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00187.2025 · Cited by 2
Youth-onset type 2 diabetes: Advances, treatments, and challenges in prevention
Sparling, D. P., & Tryggestad, J. B. (2025) · Journal of clinical lipidology · doi:10.1016/j.jacl.2025.05.020 · Cited by 3
Tang, X., Li, B., Li, D., & Wang, Y. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1619613 · Cited by 3
Zheng, H., Su, Z., Huang, S.-T., et al. (2025) · Foods · doi:10.3390/foods14203489 · Cited by 2
“Insulin resistance in skeletal muscle is a key factor in the impairment of insulin function, and reduced glucose uptake capacity in skeletal muscle significantly contributes to the development and progression of type 2 diabetes [32].”
Pediatric Sarcopenia: What do We Know?
Marques, M., & Baptista, F. (2025) · Acta Médica Portuguesa · doi:10.20344/amp.23301 · Cited by 8
Meng, X., Bu, Z., Li, X., Ren, J., Dai, Y., & Zhang, S. (2025) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s525913 · Cited by 2
“35 The stimulation of inflammatory factors can also lead to excessive production of reactive oxygen species (ROS), causing liver damage.”
Soliman, S. B., Leuteneker, J. E., Chugh, O. K., Zhang, T., Tuska, B., Rode, T., Sanchez, M. J., Buras, E. D., & Horowitz, J. F. (2025) · Journal of Ultrasound in Medicine · doi:10.1002/jum.70126 · Cited by 2
“2,28 – 30 33 Although the hyperinsulinemic-euglycemic clamp is considered the gold standard for assessing insulin resistance, 2,25,34,35 we used the Matsuda Index due to its strong correlation with clamp-derived measures, lower invasiveness, and greater practicality for clinical research.”
Oral gene delivery platform based on glycol chitosan-PEG-lactoferrin conjugate
Jang, S., Priscilla, L., Lee, C. W., Lee, S. A., Lee, M., & Lee, D. Y. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.114463 · Cited by 2
Bánovčinová, A., Schusterová, I., Tóth, Š., Porubän, T., Pella, D., Dvorožňáková, M., & Fülöp, P. (2025) · Nutrients · doi:10.3390/nu17233715 · Cited by 2
“Skeletal muscle, which comprises 30–40% of body weight, is responsible for up to 80% of insulin-mediated glucose disposal [15].”
Vidal, P., Janzen, N. R., & Brozinick, J. T. (2025) · Skeletal Muscle · doi:10.1186/s13395-025-00405-2 · Cited by 4
“linked to improvements in insulin sensitivity [6, 7], skeletal muscle function [4], and increases in skeletal muscle mass [5].”
Tang, J., Ye, W., He, L., Zhou, D., Chang, L., You, Z., Jiang, Y., Tang, G., Deng, L., & Li, C. (2025) · Advanced Science · doi:10.1002/advs.202512424 · Cited by 5
“The skeletal muscle is the primary organ responsible for glucose uptake in response to insulin stimulation [ 80 ].”
Moon, S. J., Hu, Y., Dzieciątkowska, M., Kim, A., Chen, P.-L., Asara, J. M., D’Alessandro, A., & Perrimon, N. (2026) · Nature Communications · doi:10.1038/s41467-026-68395-3 · Cited by 9
“We de fi ned a high sugar diet (HSD)-muscle-GEM by constraining reaction rates to recapitulate key known features of type 2 diabetic muscle based on the literature evidence 28,29,33,34,52 – 54 .”
Zhu, X., Zhu, L., Zhang, W., Yu, Q., Chen, Y., & Xie, J. (2026) · Food Bioscience · doi:10.1016/j.fbio.2026.108299 · Cited by 2
Schmidt, P. H. S., de Souza, V. S. N., Machado, L. G., Rodrigues, J. V. A., da Cruz, J. V. R., de Souza, L. S. N., dos Santos, B. E., Hohl, A., Ronsoni, M. F., & van de Sande‐Lee, S. (2026) · Diabetes Obesity and Metabolism · doi:10.1111/dom.70529 · Cited by 8
The Therapeutic Potential of Novel Drug Targets in Metabolic Disorders- A Review
Mishra, R., Jakhar, M., Dhiman, R., Khan, L., Raj, A., Devi, V., Kumari, A., & Kumar, A. (2026) · Biomedical & Pharmacology Journal · doi:10.13005/bpj/3333 · Cited by 2
The hallmarks of skeletal muscle health
Vainshtein, A., Blaauw, B., Bock, K. D., Muñoz‐Cánoves, P., Olson, E. N., Ottenheijm, C. A. C., Richter, E. A., Ruas, J. L., Schaeffer, L., Spiegelman, B. M., et al. (2026) · Nature Metabolism · doi:10.1038/s42255-026-01595-9 · Cited by 6
“In metabolic disorders such as type 2 diabetes, impaired muscle insulin signalling and altered myokine secretion disrupt communication with liver and adipose tissue, amplifying systemic insulin resistance and metabolic inflexibility 276,297,298 .”
Acara, A. Ç., & Güler, A. (2019) · Journal of Basic and Clinical Health Sciences · doi:10.30621/jbachs.2019.628 · Cited by 2
there any association of metabolic disturbances with joint destruction and pain?
Chetina, E. V., Markova, G. A., & Sharapova, E. P. (2019) · Biomeditsinskaya Khimiya · doi:10.18097/pbmc20196506441 · Cited by 2
Gibert‐Ramos, A., Baselga‐Escudero, L., & Crescenti, A. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-819621-2.00026-7 · Cited by 2
Errafii, K., Jayyous, A., Arredouani, A., Khatib, H., Azizi, F., Mohammad, R. M., Abdul‐Ghani, M. A., & Chikri, M. (2022) · All Life · doi:10.1080/26895293.2022.2033853 · Cited by 2
Tissue-Specific Variations in Transcription Factors Elucidate Complex Immune System Regulation
Lu, H., Tang, Y.-C., & Gottlieb, A. (2022) · Genes · doi:10.3390/genes13050929 · Cited by 3
“In relation to the specificity of the tissues, skeletal muscle insulin resistance is the primary defect in type 2 diabetes [68,69].”
BackgroundFortes, J. S., Pinto, R. M., de Souza, R. F., Godoy, F. R., da Cruz, R. S., Silva, D. D. M. E., Filho, H. P. L., da Cruz, A. D., & Minasi, L. B. (2023) · BMC Pediatrics · doi:10.1186/s12887-023-03905-6 · Cited by 2
“Insulin resistance is related to the decrease of insulin capacity to uptake glucose [37] and it may contribute to becoming a risk group for the development of metabolic syndrome in children [38].”
BackgroundLunde, N. N., Osoble, N. M. M., Dalmao‐Fernández, A., Antobreh, A. S., Jafari, A., Singh, S. K., Nyman, T. A., Rustan, A. C., Solberg, R., & Thoresen, G. H. (2023) · Biomedicines · doi:10.3390/biomedicines11112908 · Cited by 4
“Skeletal muscles also have important roles in glucose disposal by accounting for 80% of insulin-stimulated glucose uptake [12].”
BackgroundBaek, J. G., Park, D. H., Vu, N. K., Muvva, C., Hwang, H., Song, S., Lee, H., Kim, T., Kwon, H. C., Park, K., et al. (2024) · Plants · doi:10.3390/plants13050608 · Cited by 2
“It also enhances insulin sensitivity in skeletal muscle cells by promoting glucose uptake [24].”
BackgroundAli, S. S., Bahadar, H., Shah, H., et al. (2024) · Pakistan BioMedical Journal · doi:10.54393/pbmj.v7i03.1063 · Cited by 2
Ghaffar, S., Waraich, R. S., Orfali, R. S., Al‐Taweel, A. M., Aati, H. Y., Kamran, S., & Perveen, S. (2024) · Molecules · doi:10.3390/molecules29153649 · Cited by 3
“To monitor the e ff ect of the anti-AGE compound on glucose uptake in muscle cells of diabetic mice, we measured glucose uptake in primary muscle cells of diabetic mice by enzymatic fl uorescence assay [26,27].”
BackgroundMethodDiscovery of Palindrome Dual PPARγ‐GPR40 Agonists for Treating Type 2 Diabetes
Rodríguez-Luévano, A., Almanza-Pérez, J. C., Ortíz‐Andrade, R., Lara‐González, S., Santillán, R., Navarrete‐Vázquez, G., Giacoman‐Martínez, A., Lazzarini-Lechuga, R. C., Bautista, E., & Hidalgo‐Figueroa, S. (2024) · ChemMedChem · doi:10.1002/cmdc.202400492 · Cited by 2
Yan, X., Lu, Y., Zhang, H., Zhu, C., Tian, L., Chen, J., He, E., & Li, Y. (2024) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2024.105621 · Cited by 4
Bhandari, R., Lukas, K., Lee, K., Shamunee, J., Almeida, B., Guzman, T., Echevarria, M., Lindenfeld, L., Nenninger, C. H., Iukuridze, A., et al. (2024) · Pediatric Blood & Cancer · doi:10.1002/pbc.31369 · Cited by 2
“9,10 Interventions that leverage the mechanis-ticlinkbetweendiabetesandsarcopeniahavethepotentialtoimprove insulin-stimulated glucose disposal by muscle tissue.”
Nandave, M. (2024) · Springer eBooks · doi:10.1007/978-981-97-7380-0_5 · Cited by 4
Sakuragi, T., Shibata, E., Yamamoto, M., Shimajiri, S., Kondo, E., Mori, H., Tajiri, R., Nakayama, T., Yoshino, K., & Tsuji, M. (2024) · Journal of obstetrics and gynaecology research · doi:10.1111/jog.16163 · Cited by 2
“15 Amino acid transport decreases amino acid uptake into muscle and decreases protein synthesis.”
Granic, A., Cooper, R., Hurst, C., Hillman, S. J., Dodds, R. M., Witham, M. D., & Sayer, A. A. (2024) · European Geriatric Medicine · doi:10.1007/s41999-024-01119-2 · Cited by 2
“Insulin resistance in skeletal muscle is viewed as the initiating or primary defect in type 2 diabetes [7].”
Wang, J.-R., Jurado-Aguilar, J., Barroso, E., Rodríguez‐Calvo, R., Camins, A., Wahli, W., Palomer, X., & Vázquez‐Carrera, M. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-024-01972-5 · Cited by 5
“Skeletal muscle accounts for most of the insulin-stimulated glucose use and, thus, is the primary tissue affected by insulin resistance [2].”
Lee, J., Chen, X., Fanning, K. M., Si, C., Davis, A., Wasserman, D. H., Bracy, D. P., Furdui, C. M., & Kavanagh, K. (2025) · Radiation Research · doi:10.1667/rade-23-00223.1 · Cited by 2
Mao, L., Xie, Q., Cheng, Q., Tang, W., & Mao, L. (2025) · Journal of Functional Foods · doi:10.1016/j.jff.2025.106749 · Cited by 2
Huang, Q., Chen, L., Ouyang, W., Jie, X., Fu, L., Tang, F., Wang, J., Wu, Y., & Liu, X. (2025) · International Urology and Nephrology · doi:10.1007/s11255-025-04457-7 · Cited by 3
Marchant, E. D., Singh, E., Kureel, S. K., et al. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00470.2024 · Cited by 2
Sivasengh, R., Scott, A., & Gabriel, B. M. (2025) · Biology Open · doi:10.1242/bio.061941 · Cited by 3
“Insulin resistance of skeletal muscle is recognised as a key driver of T2D disease (DeFronzo and Tripathy, 2009).”
Shao, L., Chen, S., Wu, Y., Chen, L., Zhang, Y., Zhou, Y., Zhang, J., Huang, G., Sun, P., & Wen, M. (2025) · Scientific Reports · doi:10.1038/s41598-025-13037-9 · Cited by 2
“In addition, muscle is the main organ for glucose uptake and metabolism 58 .”
Donnelly, C., Menoud, V., Kayser, B., Jacovetti, C., & Regazzi, R. (2025) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00284.2025 · Cited by 3
Chantarasakha, K., Yangchum, A., Isaka, M., & Tepaamorndech, S. (2025) · Natural Products and Bioprospecting · doi:10.1007/s13659-025-00546-3 · Cited by 2
“However, since skeletal muscle is the primary site of insulin-mediated glucose disposal, and insulin resistance in this tissue often precedes the onset of systemic T2D [22, 23], it is essential to determine whether nidulin can similarly enhance glucose uptake in myotubes.”
Geng, Y., Gu, S., Fan, Y., Lu, X., Zhou, Z., Zhang, N., Pei, Y., Lu, X., Borné, Y., & Ke, C. (2025) · American Journal of Clinical Nutrition · doi:10.1016/j.ajcnut.2025.09.018 · Cited by 5
Insulin signaling pathway in the masseter muscle of dexamethasone-treated rats
de França, I. R., Santos, D. M., Moreira, G., Lima, F. B., Carvalho, C. R. D. O., & Marçal, A. C. (2018) · Interventional Medicine and Applied Science · doi:10.1556/1646.10.2018.44 · Cited by 2
“Various skeletal muscle territories, such as the tibialis anterior, extensor digitorum longus [22], soleus, epitrochleoanconeus [27, 28], and gastrocnemius [29] muscles, have been used as experimental models to assess the intracellular insulin signaling pathway under different metabolic conditions [30].”
MethodYue, X.-Y., Sun, X., Che, K., Hu, J., Lv, W., Sun, X., Geng, Z., Chi, J., & Wang, Y. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.06.055 · Cited by 3
Zong, J., Tang, Y., Wang, T., Ullah, I., Xu, K., Wang, J., Chen, P., Chen, Z., Zhu, T., Chen, J., et al. (2022) · Journal of the American Heart Association · doi:10.1161/jaha.121.025058 · Cited by 2
Slow early growers have more muscle in relation to adult activity: evidence from Cebu, Philippines
Workman, M., McDade, T. W., Adair, L. S., & Kuzawa, C. W. (2015) · European Journal of Clinical Nutrition · doi:10.1038/ejcn.2015.18 · Cited by 2
“As the primary site of insulin-mediated glucose disposal in the body, the mass of skeletal muscle may be an important determinant of glucose uptake and insulin sensitivity [1], and prior research has identified low muscle mass as a likely contributor to individual diabetes risk [3-5].”
BackgroundAmino Acid Supplements and Diabetes
Nisoli, E., Aquilani, R., & D’Antona, G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-397153-1.00009-3 · Cited by 3
Lipidomic Changes in Skeletal Muscle in Patients after Biliopancreatic Diversion
Mehnert, C. S., Graessler, J., Kamvissi, V., Castagneto‐Gissey, L., Mariolo, J. R. C., Casella, G., Mingrone, G., & Bornstein, S. R. (2017) · Hormone and Metabolic Research · doi:10.1055/s-0043-120065 · Cited by 2
“Particularly the foregut bypass is associated with a profound improvement of insulin sensitivity, most prominently seen in liver, adipocytes, and skeletal muscle [3].”
BackgroundAhmed-Sorour, H., Aal, F. A., & Elgalil, M. M. A. (2019) · The Egyptian Journal of Histology · doi:10.21608/ejh.2018.4950.1027 · Cited by 2
“The reduction in body weight that was recorded among senile diabetic rats (GII) is in agreement with DeFronzo & Tripathy[33], who reported the association between insulin resistance in type 2 diabetes, elevated rates of lipolysis, increased plasma non esterified fatty acids (FFAs) and triglyceride concentrations with…”
ResultInsulin resistance: is it a feedback mechanism or a therapeutic target in type 2 diabetes?
Eapen, J. T. (2019) · International Journal of Research in Medical Sciences · doi:10.18203/2320-6012.ijrms20193421 · Cited by 2
Miyatake, Y., Izumi-Mishima, Y., Tsutsumi, R., Otani, T., Suemasa, N., Masumoto, S., Kuroda, M., & Sakaue, H. (2020) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2020.05.165 · Cited by 2
Zhou, Y., Tan, Y., Hou, G., Ren, Y., Deng, Y., Yan, K., Zhang, Y., Lin, L., Lou, X., & Liu, S. (2020) · Rapid Communications in Mass Spectrometry · doi:10.1002/rcm.8869 · Cited by 3
Cellular Basis of Insulin Resistance: A Tale of the Microvasculature
Liu, Z. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-819801-8.00015-6 · Cited by 2
Gliquidone ameliorates hepatic insulin resistance in streptozotocin-induced diabetic Sur1−/− rats
Zhang, R., Zhou, X., Sheng, Q., Zhang, Q., Xie, T., Xu, C., Zou, Z., Dong, J., & Liao, L. (2021) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2021.174221 · Cited by 3
Reyad‐ul‐Ferdous, M., & Song, Y. (2021) · Physiology and Pharmacology · doi:10.52547/phypha.26.4.8 · Cited by 2
Profiling the Skeletal Muscle Proteome in Patients on Atypical Antipsychotics and Mood Stabilizers
Burghardt, K. J., Calme, G., Caruso, M. A., Howlett, B. H., Sanders, E., Msallaty, Z., Mallisho, A., Seyoum, B., Qi, Y. A., Zhang, X., et al. (2022) · Brain Sciences · doi:10.3390/brainsci12020259 · Cited by 5
“The skeletal muscle has been demonstrated to be the primary tissue in insulin-stimulated glucose uptake and therefore dysregulation within this tissue is thought to be central to insulin resistance [16,17].”
BackgroundRazan, M. R., Akther, F., Islam, R. A., Graham, J. L., Stanhope, K. L., Havel, P. J., & Rahimian, R. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.900813 · Cited by 3
“Although β-cell failure is a common characteristic of T2D, SKM insulin resistance and reduced glucose clearance are considered the initiating factors that lead to overt hyperglycemia and β-cell dysfunction (Warram et al., 1990; DeFronzo and Tripathy, 2009).”
BackgroundApol9a regulates myogenic differentiation via the ERK1/2 pathway in C2C12 cells
Jiang, X. J., Ji, S., Cui, S., Wang, R., Wang, W., Chen, Y. Q., & Zhu, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.942061 · Cited by 2
“Diabetes is reportedly stimulated during obesity because of a failure in appropriate glucose utilization by skeletal muscle, which is the primary target site of insulin-stimulated glucose uptake (DeFronzo and Tripathy, 2009; Lingvay et al., 2021; Mengeste et al., 2021).”
Background
Metadata
- Authors
- DeFronzo, R. A., & Tripathy, D.
- Affiliations
- The University of Texas at San Antonio Health Science Center (US)
- Corresponding author
- Tripathy, Devjit
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2009-11-01
- Volume
- 32
- Issue
- suppl_2
- Pages
- S157-S163
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC2811436
- OpenAlex
- W2170869159
- Cited by
- 2,102
- References
- 115
- Citations by year
- 2026: 149 · 2025: 188 · 2024: 187 · 2023: 161 · 2022: 200 · 2021: 199 · 2020: 161 · 2019: 146 · 2018: 166 · 2017: 132 · 2016: 119 · 2015: 99 · 2014: 72 · 2013: 54 · 2012: 29
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- skeletal muscle insulin resistance, type 2 diabetes, insulin resistance, beta-cell failure, type 2 diabetes pathogenesis, glucose tolerance, hyperglycemia
- MeSH terms
- Insulin Secretion, Blood Glucose, Diabetes Mellitus, Type 2, Fatty Acids, Nonesterified, Homeostasis, Humans, Insulin, Insulin Resistance, Glucose Clamp Technique, Muscle, Skeletal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-30, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-30 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.